Catalyst Wire Dossier Catalyst Wire Dossier

WX-554

· Heidelberg Pharma AG
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for WX-554, covering 2014-05-16 to 2014-05-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours [Phase 1, Phase 2]

See pricing